179 related articles for article (PubMed ID: 35466606)
1. [LIFESTYLE ADJUSTMENT AS THERAPEUTIC TOOL IN THYROID EYE DISEASE].
Vashdi I; Gur Z
Harefuah; 2022 Apr; 161(4):223-227. PubMed ID: 35466606
[TBL] [Abstract][Full Text] [Related]
2. Cigarette smoking and thyroid eye disease: a systematic review.
Thornton J; Kelly SP; Harrison RA; Edwards R
Eye (Lond); 2007 Sep; 21(9):1135-45. PubMed ID: 16980921
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of thyroid eye disease in Graves' disease: A meta-analysis and systematic review.
Chin YH; Ng CH; Lee MH; Koh JWH; Kiew J; Yang SP; Sundar G; Khoo CM
Clin Endocrinol (Oxf); 2020 Oct; 93(4):363-374. PubMed ID: 32691849
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors of Thyroid Eye Disease.
Lee MH; Chin YH; Ng CH; Nistala KRY; Ow ZGW; Sundar G; Yang SP; Khoo CM
Endocr Pract; 2021 Mar; 27(3):245-253. PubMed ID: 33655885
[TBL] [Abstract][Full Text] [Related]
5. Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy.
Edmunds MR; Boelaert K
Thyroid; 2019 Apr; 29(4):557-562. PubMed ID: 30688164
[TBL] [Abstract][Full Text] [Related]
6. Thyroid Eye Disease: Epidemiology, Natural History, and Risk Factors.
Bartalena L; Gallo D; Tanda ML; Kahaly GJ
Ophthalmic Plast Reconstr Surg; 2023 Dec; 39(6S):S2-S8. PubMed ID: 38054980
[TBL] [Abstract][Full Text] [Related]
7. Thyroid eye disease: what is new to know?
Li Z; Cestari DM; Fortin E
Curr Opin Ophthalmol; 2018 Nov; 29(6):528-534. PubMed ID: 30124533
[TBL] [Abstract][Full Text] [Related]
8. Thyroid-associated ophthalmopathy in juvenile Graves' disease--clinical, endocrine and therapeutic aspects.
Krassas GE; Gogakos A
J Pediatr Endocrinol Metab; 2006 Oct; 19(10):1193-206. PubMed ID: 17172081
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of Diabetic and Nondiabetic Patients With Thyroid Eye Disease in the United States: A Claims-Based Analysis.
Patel VK; Padnick-Silver L; D'Souza S; Bhattacharya RK; Francis-Sedlak M; Holt RJ
Endocr Pract; 2022 Feb; 28(2):159-164. PubMed ID: 34781042
[TBL] [Abstract][Full Text] [Related]
10. A 'Real Life' Service Evaluation Model for Multidisciplinary Thyroid Eye Services.
Farag S; Feeney C; Lee V; Nagendran S; Jain R; Aziz A; Akishar R; Bravis V; Meeran K
Front Endocrinol (Lausanne); 2021; 12():669871. PubMed ID: 34025584
[TBL] [Abstract][Full Text] [Related]
11. Prognostic indicators for the development of strabismus among patients with graves' ophthalmopathy.
Lin TY; Li N; Yeh MW; Leung AM; Rootman DB
J Clin Transl Endocrinol; 2017 Sep; 9():38-40. PubMed ID: 29067268
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of Graves' disease in patients with thyroid eye disease].
Sviridenko NY; Sheremeta MS; Belovalova IM; Melnichenko GA
Vestn Oftalmol; 2021; 137(6):128-135. PubMed ID: 34965078
[TBL] [Abstract][Full Text] [Related]
13. Selenium supplementation in thyroid eye disease: an updated review from a clinical ophthalmic perspective.
Foos W; Maliakkal Hernandez J; Mansour TN
Orbit; 2023 Nov; ():1-11. PubMed ID: 37976183
[TBL] [Abstract][Full Text] [Related]
14. Selenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial.
Watt T; Cramon P; Bjorner JB; Bonnema SJ; Feldt-Rasmussen U; Gluud C; Gram J; Hansen JL; Hegedüs L; Knudsen N; Bach-Mortensen P; Nolsøe R; Nygaard B; Pociot F; Skoog M; Winkel P; Rasmussen AK
Trials; 2013 Apr; 14():119. PubMed ID: 23782950
[TBL] [Abstract][Full Text] [Related]
15. Update on thyroid eye disease: Regional variations in prevalence, diagnosis, and management.
Yu CY; Ford RL; Wester ST; Shriver EM
Indian J Ophthalmol; 2022 Jul; 70(7):2335-2345. PubMed ID: 35791115
[TBL] [Abstract][Full Text] [Related]
16. [REDUCTION OF MORBIDITY RATE IN THYROID EYE DISEASE PATIENTS].
Achiron A
Harefuah; 2022 Apr; 161(4):221-222. PubMed ID: 35466605
[TBL] [Abstract][Full Text] [Related]
17. [Pathogenesis of thyroid eye disease - does autoimmunity against the TSH receptor explain all cases?].
Wall JR; Lahooti H
Endokrynol Pol; 2011; 62 Suppl 1():1-7. PubMed ID: 22125104
[TBL] [Abstract][Full Text] [Related]
18. Socioeconomic Disparities in the Presentation and Treatment of Graves' Disease and Thyroid Eye Disease.
Vargason CW; Chelnis JG; Barahimi BI; Mawn LA
Semin Ophthalmol; 2016; 31(4):409-14. PubMed ID: 27385363
[TBL] [Abstract][Full Text] [Related]
19. Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit.
Mellington FE; Dayan CM; Dickinson AJ; Hickey JL; MacEwen CJ; McLaren J; Perros P; Rose GE; Uddin J; Vaidya B; Foley P; Lazarus JH; Mitchell A; Ezra DG;
Orbit; 2017 Jun; 36(3):159-169. PubMed ID: 28296512
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of multimodal clinical biomarkers in the management of thyroid eye disease.
Poon SHL; Cheung JJ; Shih KC; Chan YK
Rev Endocr Metab Disord; 2022 Jun; 23(3):541-567. PubMed ID: 35066781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
